Verve Therapeutics Inc. (VERV)
NASDAQ: VERV
· Real-Time Price · USD
11.13
0.03 (0.27%)
At close: Jul 24, 2025, 3:59 PM
Verve Therapeutics Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
PE Ratio | -3.27 | -2.45 | -2.04 | -2.11 | -5.45 | -5.02 | -4.58 | -5.38 | -4.87 | -7.24 | -10.56 | -4.68 | -9.75 | -14.13 | -24.79 | -13.64 | -26.37 |
PEG Ratio | 0.08 | 1.44 | n/a | n/a | 0.38 | 1.21 | 0.27 | -0.31 | -0.47 | 0.42 | 8.66 | -0.11 | 0.91 | -0.37 | 0.43 | -0.05 | 0.42 |
PS Ratio | 12.31 | 37.46 | 59.67 | 62.68 | 186.70 | 188.81 | 268.91 | 555.01 | 634.60 | 1.18K | 2.12K | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 0.86 | 0.99 | 0.81 | 0.77 | 1.82 | 1.62 | 1.82 | 2.50 | 1.75 | 2.16 | 3.59 | 2.51 | 3.34 | 4.96 | 5.86 | 7.13 | -18.3 |
P/FCF Ratio | -13.96 | -11.6 | -10.1 | -11.94 | -24.43 | -22.66 | -65.12 | -22.95 | -16.98 | -31.41 | -61.77 | -25.23 | -30.44 | -61.01 | -100.89 | -197.23 | -86.29 |
P/OCF Ratio | -14.57 | -12 | -10.34 | -12.28 | -24.68 | -23.87 | -70.97 | -24.22 | -18.15 | -36.16 | -67.35 | -27.8 | -33.08 | -63.14 | -105.63 | -216.54 | -92.39 |
OCF/S Ratio | -0.84 | -3.12 | -5.77 | -5.1 | -7.56 | -7.91 | -3.79 | -22.92 | -34.97 | -32.5 | -31.4 | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0.14 | 0.14 | 0.14 | 0.13 | 0.13 | 0.12 | 0.17 | 0.17 | 0.16 | 0.15 | 0.15 | 0.00 | 0.00 | 0.01 | 0.01 | n/a | -2.86 |
Quick Ratio | 9.84 | 12.65 | 13.05 | 14.64 | 19.82 | 17.24 | 14.41 | 14.32 | 15.43 | 16.05 | 19.35 | 11.55 | 22.21 | 16.67 | 19.48 | 48.51 | 22.72 |
Current Ratio | 9.84 | 12.65 | 13.05 | 14.64 | 19.82 | 17.24 | 14.41 | 14.32 | 15.16 | 16.05 | 19.35 | 11.55 | 22.21 | 16.67 | 19.48 | 48.51 | 22.72 |
Asset Turnover | 0.05 | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Return on Equity | -0.07 | -0.1 | -0.1 | -0.09 | -0.08 | -0.08 | -0.1 | -0.12 | -0.09 | -0.07 | -0.08 | -0.13 | -0.09 | -0.09 | -0.06 | -0.13 | 0.17 |
Return on Assets | -0.05 | -0.08 | -0.08 | -0.07 | -0.07 | -0.06 | -0.07 | -0.09 | -0.07 | -0.06 | -0.07 | -0.12 | -0.08 | -0.08 | -0.06 | -0.12 | -0.08 |
Return on Invested Capital | -0.06 | -0.09 | -0.09 | -0.09 | -0.08 | -0.07 | -0.09 | -0.1 | -0.08 | -0.07 | -0.07 | -0.14 | -0.09 | -0.09 | -0.06 | -0.04 | -0.09 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | -0.94 | -3.83 | -7.3 | -7.44 | -8.56 | -9.4 | -14.68 | -25.79 | -32.54 | -40.6 | -50.08 | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | -0.94 | -3.82 | -7.29 | -7.43 | -8.54 | -9.39 | -14.66 | -25.71 | -37.02 | -40.55 | -48.64 | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | -1.11 | -4.29 | -8.29 | -8.79 | -9.98 | -10.49 | -16.79 | -27.99 | -41.5 | -47.14 | -47.21 | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | -1.06 | -4.16 | -8.03 | -8.54 | -9.69 | -10.19 | -16.32 | -27.35 | -40.69 | -46.23 | -46.44 | n/a | n/a | n/a | n/a | n/a | n/a |